ClinicalTrials.Veeva

Menu

Preventing Adverse Drug Events With PatientSite

Dana-Farber Cancer Institute logo

Dana-Farber Cancer Institute

Status

Completed

Conditions

Adverse Drug Event

Treatments

Other: Medcheck message

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT00140504
05-061
Weingart - K08HS11644

Details and patient eligibility

About

This is a study to better understand the nature and extent of adverse drug events (ADEs), defined as injuries due to prescription medications, in primary care. We will study whether PatientSite (an internet-based communication program for patients and health care providers) can improve clinicians' ability to detect adverse drug events among primary care patients and to mitigate the consequences by sending electronic queries to patients after they receive new medication prescriptions.

Full description

  • A drug safety module called MedCheck was developed for PatientSite. This allows physicians to query patients automatically 10 days after they receive a new prescription asking them questions about their new prescription. In this study new enhancements will be tested.
  • Participants will be assigned at random to the intervention group or control group. The intervention group will receive a single electronic PatientSite message asking them questions about the new prescription which is then forwarded to their physician. The control group will receive a generic message about medication safety.
  • To identify adverse drug events, a telephone survey and medical record review will be conducted of patients in the intervention group and controls.
  • This study will run for 12 months.

Enrollment

800 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Adult patients >18
  • Patients that receive a new prescription
  • Proficient in spoken and written english

Exclusion Criteria:

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

800 participants in 2 patient groups

MedCheck
Experimental group
Description:
Electronic medication safety queries via PatientSite portal
Treatment:
Other: Medcheck message
Usual care
No Intervention group
Description:
No electronic medication safety messages via PatientSite portal

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems